ArticleFrontiers in oncology2020

Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis

Kyeong Seok Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.